
    
      Symptomatic menopausal women will be divided to treatment with Femarelle or placebo for 12
      weeks after two weeks of baseline record. Hot flashes daily diary will be recorded daily and
      a quality of life questionnaire will be filled at the beginning and at completion of the
      study.
    
  